Search Results - "CLARK, J. I"

Refine Results
  1. 1

    Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial by Escudier, B, Michaelson, M D, Motzer, R J, Hutson, T E, Clark, J I, Lim, H Y, Porfiri, E, Zalewski, P, Kannourakis, G, Staehler, M, Tarazi, J, Rosbrook, B, Cisar, L, Hariharan, S, Kim, S, Rini, B I

    Published in British journal of cancer (10-06-2014)
    “…Background: In the AXIS trial, axitinib prolonged progression-free survival (PFS) vs sorafenib in patients with advanced renal cell carcinoma (RCC) previously…”
    Get full text
    Journal Article
  2. 2

    Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions by Atkins, M.B., Clark, J.I., Quinn, D.I.

    Published in Annals of oncology (01-07-2017)
    “…In recent years, there has been dramatic expansion of the treatment armamentarium for patients with advanced renal cell carcinoma (aRCC), including drugs…”
    Get full text
    Journal Article
  3. 3

    Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer by Almand, Bond, Clark, Joseph I, Nikitina, Ekaterina, van Beynen, James, English, Nicholas R, Knight, Stella C, Carbone, David P, Gabrilovich, Dmitry I

    Published in The Journal of immunology (1950) (01-01-2001)
    “…Defective dendritic cell (DC) function caused by abnormal differentiation of these cells is an important mechanism of tumor escape from immune system control…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence by Petruzzelli, G.J., MD, PhD, FACS, Howell, J.B., MD, Pederson, A., MD, Origitano, T.C., MD, PhD, FACS, Byrne, R.W., MD, Munoz, L., MD, Emami, B., MD, Clark, J.I., MD

    Published in American journal of otolaryngology (01-07-2015)
    “…Abstract Purpose Esthesioneuroblastoma is an uncommon malignancy of the head and neck for which there is no defined treatment protocol. The purpose of this…”
    Get full text
    Journal Article
  6. 6

    Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy by Tapscott, Stephen J, Klesert, Todd R, Cho, Diane H, Clark, John I, Maylie, James, Adelman, John, Snider, Lauren, Yuen, Eric C, Soriano, Philippe

    Published in Nature genetics (01-05-2000)
    “…Expansion of a CTG trinucleotide repeat in the 3′ UTR of the gene DMPK at the DM1 locus on chromosome 19 causes myotonic dystrophy, a dominantly inherited…”
    Get full text
    Journal Article
  7. 7

    Outpatient Biochemotherapy With Interleukin-2 and Interferon Alfa-2b in Patients With Metastatic Malignant Melanoma: Results of Two Phase II Cytokine Working Group Trials by FLAHERTY, L. E, ATKINS, M, SOROKIN, P, FISHER, R. I, APPEL, C, DU, W, SOSMAN, J, WEISS, G, CLARK, J. I, MARGOLIN, K, DUTCHER, J, GORDON, M. S, LOTZE, M, MIER, J

    Published in Journal of clinical oncology (01-07-2001)
    “…The Cytokine Working Group performed a randomized phase II trial of two outpatient biochemotherapy regimens to identify an outpatient regimen with high…”
    Get full text
    Journal Article
  8. 8

    SPARC deficiency leads to early-onset cataractogenesis by Norose, K, Clark, JI, Syed, NA, Basu, A, Heber-Katz, E, Sage, EH, Howe, CC

    “…To determine the role of SPARC (secreted protein, acidic, and rich in cysteine) in cataractogenesis by examining mice deficient in a matricellular protein…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Inhibition of lens opacification during the early stages of cataract formation by Hiraoka, T, Clark, JI

    “…To characterize the time period during cataract formation in which administration of pantethine inhibits lens cell opacification in the selenite model for…”
    Get full text
    Journal Article
  11. 11

    Fibroblast Growth Factor-2 Selectively Stimulates Angiogenesis of Small Vessels in Arterial Tree by Parsons-Wingerter, Patricia, Elliott, Katherine E, Clark, John I, Farr, Andrew G

    “…There is a critical need for quantifiable models of angiogenesis in vivo, and in general, differential effects of angiogenic regulators on vascular morphology…”
    Get full text
    Journal Article
  12. 12

    The influence of grain boundary impedances on the p-type conductivity of undoped BaTiO3 ceramics by CLARK, I. J, MARQUES, F. B, SINCLAIR, D. C

    Published in Journal of the European Ceramic Society (01-04-2002)
    “…Impedance spectroscopy is used to deconvolute the dc conductivity (sigma) of undoped BaTiO3 ceramics (about 95% of the theoretical X-ray density) into bulk…”
    Get full text
    Journal Article
  13. 13

    Phase I trial and 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and FcγRIII by WEINER, L. M, CLARK, J. I, DAVEY, M, LI, W. S, GARCIA DE PALAZZO, I, RING, D. B, ALPAUGH, R. K

    Published in Cancer research (Chicago, Ill.) (15-10-1995)
    “…2B1 is a bispecific murine monoclonal antibody (BsMAb) with specificity for the c-erbB-2 and Fc gamma RIII extracellular domains. This BsMAb promotes the…”
    Get full text
    Journal Article
  14. 14

    Quantitative analysis of the microstructure of the human cornea and sclera using 2-D Fourier methods by Vaezy, S, Clark, J I

    Published in Journal of microscopy (Oxford) (01-08-1994)
    “…A two-dimensional (2-D) Fourier analysis was used to characterize the microstructure of the human cornea and sclera. The average centre-to-centre spacing of…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Digital image capture and quantification of subtle lens opacities in rodents by Seeberger, T M, Matsumoto, Y, Alizadeh, A, Fitzgerald, P G, Clark, J I

    Published in Journal of biomedical optics (01-01-2004)
    “…A rapid, sensitive, and cost-effective method is reported for the subjective and objective documentation of subtle opacities in lenses of unanesthetized…”
    Get more information
    Journal Article
  17. 17

    Fourier and power law analysis of structural complexity in cornea and lens by Clark, J I

    Published in Micron (Oxford, England : 1993) (01-04-2001)
    “…The ordered pattern of type I collagen fibrils in the transparent cornea is an example of specialization in the formation of functional ultrastructure. In…”
    Get full text
    Journal Article
  18. 18

    Effect of Selected Anti-cataract Agents on Opacification in the Selenite Cataract Model by HIRAOKA, T., CLARK, J.I., LI, X.Y., THURSTON, G.M.

    Published in Experimental eye research (1996)
    “…A systematic study of the anti-cataract activity of 14 reagents was conducted using the selenite model. The reagents or their derivatives were identified from…”
    Get full text
    Journal Article
  19. 19

    Clinical Significance of Defective Dendritic Cell Differentiation in Cancer by Almand, B, Resser, J R, Lindman, B, Nadaf, S, Clark, J I, Kwon, E D, Carbone, D P, Gabrilovich, D I

    Published in Clinical cancer research (01-05-2000)
    “…Defective dendritic cell (DC) function has been described previously in cancer patients and tumor-bearing mice. It can be an important factor in the escape of…”
    Get full text
    Journal Article
  20. 20

    Loss of Cytoskeletal Proteins and Lens Cell Opacification in the Selenite Cataract Model by MATSUSHIMA, HIROYUKI, DAVID, LARRY L., HIRAOKA, TOSHIHIKO, CLARK, JOHN I.

    Published in Experimental eye research (01-03-1997)
    “…This study of lens protein composition found that some cytoskeletal proteins were degraded during the earliest stages of cataract formation. Cataract was…”
    Get full text
    Journal Article